Literature DB >> 11749749

Prevalence and genetic profiling of virulence determinants of non-O157 Shiga toxin-producing Escherichia coli isolated from cattle, beef, and humans, Calcutta, India.

Asis Khan1, Shinji Yamasaki, Toshio Sato, Thandavarayan Ramamurthy, Amit Pal, Simanti Datta, Nandini Roy Chowdhury, Suresh Chandra Das, Asim Sikdar, Teizo Tsukamoto, Sujit Kumar Bhattacharya, Yoshifumi Takeda, Gopinath Balakrish Nair.   

Abstract

We investigated the prevalence of Shiga toxin-producing Escherichia coli (STEC) in hospitalized diarrhea patients in Calcutta, India, as well as in healthy domestic cattle and raw beef samples collected from the city's abattoir. Multiplex polymerase chain reaction using primers specific for stx1 and stx2 detected STEC in 18% of cow stool samples, 50% of raw beef samples, and 1.4% and 0.6% of bloody and watery stool samples, respectively, from hospitalized diarrhea patients. Various virulence genes in the STEC isolates indicated that stx1 allele predominated. Plasmid-borne markers, namely, hlyA, katP, espP, and etpD, were also identified. Bead enzyme-linked immunosorbent assay and Vero cell assay were performed to detect and evaluate the cytotoxic effect of the Shiga toxins produced by the strains. STEC is not an important cause of diarrhea in India; however, its presence in domestic cattle and beef samples suggests that this enteropathogen may become a major public health problem in the future.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11749749

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  25 in total

1.  Intestinal Shiga toxin-producing Escherichia coli bacteria mitigate bovine leukemia virus infection in experimentally infected sheep.

Authors:  Witold A Ferens; Rowland Cobbold; Carolyn J Hovde
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Infantile diarrhoea associated with sorbitol-fermenting, non-shiga toxin-producing Escherichia coli O157:H-.

Authors:  S Chakraborty; A Khan; S Kahali; S M Faruque; S Yamasaki; T Ramamurthy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-08       Impact factor: 3.267

3.  Comparison of a PCR-restriction fragment length polymorphism (PCR-RFLP) assay to pulsed-field gel electrophoresis to determine the effect of repeated subculture and prolonged storage on RFLP patterns of Shiga toxin-producing Escherichia coli O157:H7.

Authors:  Kensuke Shima; Yuluo Wu; Norihiko Sugimoto; Masahiro Asakura; Kazuhiko Nishimura; Shinji Yamasaki
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

4.  Enhanced surveillance of non-O157 verotoxin-producing Escherichia coli in human stool samples from Manitoba.

Authors:  Laura H Thompson; Sandra Giercke; Carole Beaudoin; David Woodward; John L Wylie
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-11       Impact factor: 2.471

5.  Shiga toxin-producing Escherichia coli infection in South India.

Authors:  Priya Rajendran; Deva Prasanna Rajan; Gagandeep Kang; Cheleste M Thorpe
Journal:  J Med Microbiol       Date:  2009-07-09       Impact factor: 2.472

6.  Antibiotic resistance, virulence gene, and molecular profiles of Shiga toxin-producing Escherichia coli isolates from diverse sources in Calcutta, India.

Authors:  Asis Khan; S C Das; T Ramamurthy; A Sikdar; J Khanam; S Yamasaki; Y Takeda; G Balakrish Nair
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

7.  Pathotypes of diarrheagenic Escherichia coli in children attending a tertiary care hospital in South India.

Authors:  Priya Rajendran; Sitara Swarna Rao Ajjampur; Divya Chidambaram; Gunasekaran Chandrabose; Bhuvaneswari Thangaraj; Rajiv Sarkar; Prasanna Samuel; Deva Prasanna Rajan; Gagandeep Kang
Journal:  Diagn Microbiol Infect Dis       Date:  2010-10       Impact factor: 2.803

8.  Development of a PCR-restriction fragment length polymorphism assay for the epidemiological analysis of Shiga toxin-producing Escherichia coli.

Authors:  Kensuke Shima; Jun Terajima; Toshio Sato; Kazuhiko Nishimura; Kazumichi Tamura; Haruo Watanabe; Yoshifumi Takeda; Shinji Yamasaki
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

9.  Shiga toxin 1 targets bovine leukemia virus-expressing cells.

Authors:  Witold A Ferens; Luke J Grauke; Carolyn J Hovde
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

10.  Antiviral activity of shiga toxin requires enzymatic activity and is associated with increased permeability of the target cells.

Authors:  Indira Basu; Witold A Ferens; Diana M Stone; Carolyn J Hovde
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.